Jacek Marek Antas

Jacek Marek Antas appears in our data through filings on Helix BioPharma Corp. shares, published by SEDI. Between 18 April 2022 and 16 August 2024, the trades on record add up to 3 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 21 August 2024: a transaction, in Helix BioPharma Corp. Typically, a trade is published a median of 5 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.